Pitt Startup Duo Oncology on the Brink of Clinical Trials for Nanomedicine Targeting Intractable Cancers
Sam Rothstein is feeling good about his decision four years ago to take the helm of Duo Oncology, a startup company initially funded by Pitt faculty/clinician oncologists excited about the …